,,ii #aah? ,,congress #a/ ,session ,s4 #bdjf ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,july #bj1 #bjbc,mr4 ,c>p] 7= himself & ,mr4 ,grassley7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ,f9ance ,a ,,bill ,to am5d title ,,xviii ( ! ,social ,security ,act to improve ov]sight ( =mul>y developm5t & managem5t "u ,m$ic>e "p ,d4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,,pbm ,ov]sight ,act ( #bjbc4 #b4 ,resolv+ conflicts ( int]e/ & improv+ ov]sight ( ,p,t ,committee ov]rides 7a7 ,9 g5]al ,section #ahfj;,d-#d7;b77#c7 ( ! ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#ajd7;b77#c77 is am5d$-- 7#a7 9 subp>agraph 7,a77ii77,i71 by ins]t+ ! foll[+ be=e ! semicolon3 7&1 = #bjbe & ea* subsequ5t ye>1 any ph>macy b5efit manag]72 & 7#b7 by add+ at ! end ! foll[+ new subp>agraph3 7,j7 ,report+ on additional committees ) =mul>y decision mak+ au?ority 7i7 ,9 g5]al ,= #bjbf & ea* subsequ5t plan ye>1 a ,,pdp sponsor %all submit to ! ,secret>y ! foll[+ in=mation1 if applicable1 ) respect to ea* prescription drug plan (f]$ by ! ,,pdp sponsor3 7,i7 ,! "n & a description ( ! role & composition ( any committee1 entity1 or individual )9 or affiliat$ ) ! ,,pdp sponsor 7or a ph>macy b5efit manag]1 act+ "u contract ) su* sponsor7 t has ! au?ority to make a cov]age1 =mul>y placem5t1 or utilization managem5t decision 7z def9$ 9 clause 7ii77,i771 o!r ?an ! ph>macy & !rapeutic committee describ$ 9 subp>agraph 7,a74 7,,ii7 ,a li/ ( drugs = :i* a committee1 entity1 or individual describ$ 9 subclause 7,i7 made a cov]age1 =mul>y placem5t1 or utilization managem5t decision 7z s def9$7 & ! correspond+ initial recomm5dation 7z def9$ 9 clause 7ii77,,ii77 made by ! ph>macy & !rapeutic committee4 7,,iii7 ,a brief ju/ification = ea* decision describ$ 9 subclause 7,,ii74 7ii7 ,def9itions ,9 ?is subp>agraph3 7,i7 ,cov]age1 =mul>y placem5t1 or utilization managem5t decision ,! t]m cov]age1 =mul>y placem5t1 or utilization managem5t decision means a decision by a committee1 entity1 or individual describ$ 9 clause 7i77,i7 t modifies1 adju/s1 rev]ses1 or o!rwise alt]s 7su* z by sub/itut+ ! =mul>y inclusion ( "o cov]$ "p ,d drug = ano!r or by sub/itut+ a m g5]al initial recomm5dation = a m specific decision7 an initial recomm5dation by ! ph>macy & !rapeutic committee4 7,,ii7 ,initial recomm5dation ,! t]m initial recomm5dation means a cov]age1 =mul>y placem5t1 or utilization managem5t decision recomm5d$ by ! ph>macy & !rapeutic committee prior to ! review1 adoption1 or modification ( su* a recomm5dation by a committee1 entity1 or individual describ$ 9 clause 7i77,i74 ,= purposes ( ?is subp>agraph1 su* initial recomm5dation %all be consid]$ to be sep>ate & di/9ct f ! f9al review & approval ( ! =mul>y design & compon5ts by su* ph>macy & !rapeutic committee1 z requir$ "u section #dbc4abj ( title #db1 ,code ( ,f$]al ,regulations 7or any successor regulation74 7iii7 ,non-application ( pap]work r$uction act ,*apt] #ce ( title #dd1 ,unit$ ,/ates ,code1 %all n apply to in=mation requir$ = purposes ( c>ry+ out ?is subp>agraph4 4 7b7 ,implem5tation ,not)/&+ any o!r provision ( law1 ! ,secret>y ( ,heal? & ,human ,s]vices may implem5t ! am5dm5ts made by subsection 7a7 by program in/ruction or o!rwise4 7c7 ,,gao /udy & report 7#a7 ,/udy ,! ,comptroll] ,g5]al %all conduct a /udy on ! use ( committees1 entities1 or individuals describ$ 9 clause 7i77,i7 ( section #ahfj;,d-#d7;b77#c77;,j7 ( ! ,social ,security ,act1 z add$ by subsection 7a71 9 ! developm5t & review ( =mul>ies "u "p ,d ( title ,,xviii ( ! ,social ,security ,act4 ,su* /udy %all include an analysis ( ! foll[+3 7,a7 ,! preval5ce ( su* committees1 entities1 or individuals4 7,b7 ,! numb]1 type1 & *>act]i/ics ( drugs = :i* a committee1 entity1 or individual describ$ 9 su* clause 7i77,i7 made a cov]age1 =mul>y placem5t1 or utilization managem5t decision 7z def9$ 9 clause 7ii77,i7 ( su* section #ahfj;,d-#d7;b77#c77;,j774 7,c7 ,tr5ds 9 ! ju/ifications provid$ "u clause 7i77,,iii7 ( su* section #ahfj;,d-#d7;b77#c77;,j74 7,d7 ,tr5ds 9 ! application ( utilization managem5t tools 7su* z prior au?orization1 /ep !rapy1 & quantity limits7 & =mul>y exclusions "u prescription drug plans & ,,ma-,,pd plans & ! impact su* tools & exclusions h on b5efici>y access to cov]$ "p ,d drugs4 7#b7 ,report ,n lat] ?an ,janu>y #a1 #bjbi1 ! ,comptroll] ,g5]al %all submit to ,congress a report conta9+ ! results ( ! /udy conduct$ "u p>agraph 7#a71 toge!r ) any recomm5dations = su* legislation & adm9i/rative action z ! ,comptroll] ,g5]al det]m9es appropriate4 7#c7 ,def9itions ,9 ?is subsection3 7,a7 ,comptroll] ,g5]al ,! t]m ,comptroll] ,g5]al means ! ,comptroll] ,g5]al ( ! ,unit$ ,/ates4 7,b7 ,o!r t]ms ,! t]ms cov]$ "p ,d drug1 ,,ma-,,pd plan1 & prescription drug plan h ! mean+ giv5 ^? t]ms 9 section #ahfj;,d-#da ( ! ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aea74